Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a Wisconsin Oncology Network Study

INTRODUCTION: Exisulind is an apoptotic agent with preclinical activity in non-small cell lung cancer (NSCLC). Vinorelbine is safe and effective in older patients with advanced NSCLC. We assessed these agents together as palliative treatment for older patients with advanced NSCLC. METHODS: Chemother...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Attia, Steven, Traynor, Anne M., Kim, KyungMann, Merchant, Joseph J., Hoang, Tien, Ahuja, Harish G., Beatty, Peter A., Hansen, Richard M., Masters, Gregory A., Oettel, Kurt R., Shapiro, Gary R., Larson, Martha M., Larson, Marilyn L., Schiller, Joan H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2562273/
https://ncbi.nlm.nih.gov/pubmed/18758305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181834fa1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados